Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

Selecting an option will change the focus to the start of the list.
  • International (410)
  • COVID-19 (170)
  • National Immunisation Programme (29)
  • Immunisation and vaccination (27)
  • Health research for COVID-19 (25)
  • Behavioural science (18)
  • Tobacco (18)
  • Circular economy (17)
  • Mental Health (16)
  • Food and Nutrition (15)
  • Flu and flu vaccine (14)
  • Heat (14)
  • Nitrogen (14)
  • PFAS (14)
  • Medical devices (13)
  • Antimicrobial resistance (12)
  • Population screening programmes (12)
  • Sexually transmitted infections (STIs) (12)
  • Soil and water (12)
  • Tick bites (12)
  • Healthy living environment (11)
  • Tuberculosis (11)
  • Physical Activity (10)
  • HPV (9)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (9)
  • One Health (9)
  • Plastics (9)
  • Public Health Monitors (9)
  • Respiratory syncytial virus (RSV) (9)
  • Food safety (8)
  • Occupational Safety (8)
  • Respiratory infections (8)
  • Sustainability (8)
  • Zoonotic diseases (8)
  • Mpox (7)
  • Salmonella (7)
  • Infectious Disease Control (6)
  • Public Health Foresight (6)
  • Wastewater research (6)
  • Whooping cough (6)
  • Lyme disease (5)
  • Tick-borne encephalitis (5)
  • Climate change (4)
  • Climate change and Health (4)
  • Dutch Food Composition Database (NEVO) (4)
  • Dutch National Food Consumption Survey (4)
  • Environmental pollution and health on Bonaire (4)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (4)
  • Rotavirus (4)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (4)
  • Bird flu (avian influenza) (3)
  • Cervical cancer screening programme (3)
  • Chromium (VI) and CARC (3)
  • Gonorrhoea (3)
  • Heel prick (3)
  • International projects (3)
  • Lifestyle interventions (3)
  • Measles (3)
  • Perinatal screening (3)
  • Pneumococci (3)
  • West Nile fever (3)
  • Alternatives to animal testing (2)
  • Breast Cancer Screening Programme (2)
  • Consumer exposure to chemical substances (2)
  • Digitale zorg (2)
  • Environmental and industrial safety (2)
  • EU Reference Laboratory for Public Health on Vector-borne Viral Pathogens (EURL-PH-VBV) (2)
  • Incidents and disasters (2)
  • Legionella (Legionellosis) (2)
  • Population screening programs in the Caribbean Netherlands (2)
  • Radiation and radioactivity (2)
  • Sustainable procurement (2)
  • UV index (2)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (2)
  • WHO Collaborating Centre for Nutrition (2)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (2)
  • WHO Collaborating Centre on Life Course and Health (2)
  • Corona (1)
  • Coronaviruses (1)
  • Doetinchem Cohort Study (1)
  • Ebola (1)
  • Group A Strep infections (1)
  • HPV - Humaan Papillomavirus (1)
  • Leefstijlmonitor (1)
  • Listeriose (Listeria) (1)
  • Livestock farming and health (1)
  • Mosquitos (1)
  • Nanotechnology and advanced materials (1)
  • Norovirus (1)
  • PFAS (1)
  • Pharmaceuticals in the environment (1)
  • Polio (1)
  • RIVM (1)
  • Shigellosis (1)
  • Sustainable Development Goals (1)
  • Tata Steel (1)
  • Water (1)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (1)

Publication date

Selecting an option will change the focus to the start of the list.
  • April 2026 (7)
  • March 2026 (10)
  • February 2026 (10)
  • January 2026 (6)
  • December 2025 (9)
  • November 2025 (9)
  • October 2025 (9)
  • September 2025 (8)
  • August 2025 (8)
  • July 2025 (4)
  • June 2025 (15)
  • May 2025 (4)
  • April 2025 (10)
  • March 2025 (12)
  • February 2025 (4)
  • January 2025 (5)
  • December 2024 (9)
  • November 2024 (13)
  • October 2024 (5)
  • September 2024 (6)
  • August 2024 (2)
  • July 2024 (6)
  • June 2024 (11)
  • May 2024 (12)
  • April 2024 (5)
  • March 2024 (10)
  • February 2024 (6)
  • January 2024 (5)
  • December 2023 (13)
  • November 2023 (9)
  • October 2023 (11)
  • September 2023 (11)
  • July 2023 (12)
  • June 2023 (7)
  • May 2023 (8)
  • April 2023 (14)
  • March 2023 (10)
  • February 2023 (15)
  • January 2023 (7)
  • December 2022 (9)
  • November 2022 (16)
  • October 2022 (17)
  • September 2022 (17)
  • August 2022 (4)
  • July 2022 (15)
  • June 2022 (12)
  • May 2022 (18)
  • April 2022 (7)
  • March 2022 (14)
  • February 2022 (12)
  • January 2022 (18)
  • December 2021 (51)
  • November 2021 (20)
  • October 2021 (11)
  • September 2021 (11)
  • August 2021 (4)
  • July 2021 (16)
  • June 2021 (33)
  • May 2021 (28)
  • April 2021 (22)
  • March 2021 (19)
  • February 2021 (19)
  • January 2021 (12)
  • December 2020 (13)
  • November 2020 (12)
  • October 2020 (8)
  • September 2020 (8)
  • August 2020 (5)
  • July 2020 (4)
  • June 2020 (12)
  • May 2020 (9)
  • April 2020 (5)
  • March 2020 (11)
  • February 2020 (4)
  • January 2020 (4)
  • December 2019 (9)
  • November 2019 (12)
  • October 2019 (4)
  • September 2019 (6)
  • August 2019 (1)
  • July 2019 (4)
  • June 2019 (13)
  • May 2019 (8)
  • April 2019 (6)
  • March 2019 (6)
  • February 2019 (3)
  • January 2019 (2)

GPs will invite under-60s with Down's syndrome or morbid obesity for GGD vaccination

People with Down's syndrome and people with morbid obesity born in 1961 or later, who have not yet been vaccinated, will receive a vaccination invitation from their GP.
16-04-2021 | 12:30

People born in 1952 invited for COVID-19 vaccination

Starting next week, the first people in the next age group will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in 1952.

15-04-2021 | 16:27

Huge leap in vaccinations: nearly 3.8 million doses administered

The vaccination figures published today in the RIVM report and on the Coronavirus Dashboard are higher than in previous weeks.

13-04-2021 | 21:58
Sander Koning

Different vaccine very soon available to people under 60, instead of AstraZeneca

Vaccination with AstraZeneca will continue for people aged 60 years and older; the vaccine is still very necessary for that target group.
13-04-2021 | 21:32

More positive tests, and rising percentage of positive tests

In the week of 7 to 13 April, 51,240 people tested positive for the coronavirus SARS-CoV-2. This is an increase of +6%, after the dip in the number of positive test results in the week of the Easter weekend.
13-04-2021 | 14:50
Woman in supermarket

Vaccination with AstraZeneca continues for people aged 60 years and older

As advised by the Health Council of the Netherlands, vaccination with AstraZeneca will be continued for people born in 1960 or before.  People under the age of 60 will receive a different vaccine.
09-04-2021 | 20:53

Fewer coronavirus infections among people who kept distancing

People who follow the advice to stay 1.5 apart from others are less likely to contract the coronavirus SARS-CoV-2.

08-04-2021 | 18:03

Coronavirus monitoring in sewage research expanded and extended

Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.
08-04-2021 | 12:19
Werkbezoek Hugo de Jonge aan een rioolwaterzuiveringsinstallatie in Leiden

Fewer cases, higher percentage of positive tests

In the week of 31 March to 6 April, 48,186 people in the Netherlands received a positive test result for COVID-19. That is a decrease of 7% compared to the week before.

06-04-2021 | 16:16

New hold on vaccination with AstraZeneca for people under 60 years

The Ministry of Health, Welfare and Sport (VWS) has decided to stop vaccinating with the COVID-19 vaccine made by AstraZeneca for people under 60 (born in 1961 or later), effectively from now until Wednesday.
02-04-2021 | 17:47
Package COVID-19 Vaccine AstraZeneca

Pagination

  • « « First
  • ‹ ‹ Previous
  • …
  • Page 65
  • Page 66
  • Page 67
  • Page 68
  • Current page 69
  • Page 70
  • Page 71
  • Page 72
  • Page 73
  • …
  • › Next ›
  • » Last »

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Social media house rules

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon